. Author manuscript; available in PMC: 2009 Nov 10.

Published in final edited form as: J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jan 16;863(1):107–114. doi: 10.1016/j.jchromb.2008.01.001

Table 2.

Compounds Evaluated for Potential Interference with Nicotine and Metabolites in Meconium by LC-APCI-MS/MS

Concentration (ng/g)	Compounds
100	Anabasine, anatabine
1,000	Δ⁹Tetrahydrocannabinol, 11-hydroxy-Δ⁹⁻tetrahydrocannabinol, 11-nor-9-carboxy-Δ⁹-tetrahydrocannabinol, diazepam, lorazepam, oxazepam, alprazolam, nitrazepam, flunitrazepam, temazepam, nordiazepam, clonidine, ibuprofen, pentazocine, caffeine, diphenhydramine, chlorpheniramine, brompheniramine, acetylsalicylic acid, acetaminophen, phencyclidine
2,000	Amphetamine, methamphetamine
3,000	Morphine, normorphine, morphine-3-glucuronide, morphine-6-glucuronide, codeine, norcodeine, 6-acetylmorphine, acetylcodeine, hydrocodone, hydromorphone, oxycodone, noroxycodone, oxymorphone, noroxymorphone
10,000	Cocaine, benzoylecgonine, norcocaine, norbenzoylecgonine, ecgonine ethyl ester, ecgonine methyl ester, anhydroecgonine methyl ester, ecgonine, cocaethylene, norcocaethylene, meta-hydroxycocaine, para-hydroxycocaine, meta-hydroxybenzoylecgonine, para-hydroxybenzoylecgonine